Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/emerald-publishing/drug-therapy-in-adhd-in-people-with-intellectual-disabilities-FQInI853EG
References (48)
-
J. Buitelaar, D. Michelson, M. Danckaerts, C. Gillberg, T. Spencer, A. Zuddas, D. Faries, Shuyu Zhang, J. Biederman (2007)
A Randomized, Double-Blind Study of Continuation Treatment for Attention-Deficit/Hyperactivity Disorder After 1 YearBiological Psychiatry, 61
-
D. Michelson, D. Faries, J. Wernicke, D. Kelsey, Katherine Kendrick, F. Sallee, T. Spencer (2001)
Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.Pediatrics, 108 5
-
Nathan Blum, Joyce Mauk, J. McComas, F. Mace (1996)
Separate and combined effects of methylphenidate and a behavioral intervention on disruptive behavior in children with mental retardation.Journal of applied behavior analysis, 29 3
-
E. Simonoff, E. Taylor, G. Baird, S. Bernard, O. Chadwick, Holan Liang, S. Whitwell, K. Riemer, K. Sharma, Santvana Sharma, N. Wood, J. Kelly, A. Golaszewski, Juliet Kennedy, L. Rodney, N. West, R. Walwyn, F. Jichi (2013)
Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.Journal of child psychology and psychiatry, and allied disciplines, 54 5
-
D. Posey, M. Aman, L. Arnold, Yaser Ramadan, Andrea Witwer, R. Lindsay, C. McDougle, N. Swiezy, Arlene Kohn, J. McCracken, Bhavik Shah, P. Cronin, J. McGough, L. Lee, L. Scahill, Andrés Martin, K. Koenig, Deirdre Carroll, Christopher Young, Allison Lancor, E. Tierney, J. Ghuman, N. Gonzalez, M. Grados, B. Vitiello, Louise Ritz, S. Chuang, M. Davies, James Robinson, D. McMahon (2005)
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.Archives of general psychiatry, 62 11
-
Dr Harpin (2005)
The effect of ADHD on the life of an individual, their family, and community from preschool to adult lifeArchives of Disease in Childhood, 90
-
L. Mazzone, Laura Reale, Valeria Mannino, M. Cocuzza, B. Vitiello (2011)
Lower IQ is Associated with Decreased Clinical Response to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity DisorderCNS Drugs, 25
-
Ching-Shu Tang, W. Chou, A. Cheng (2009)
Atomoxetine hydrochloride-associated transient psychosis in an adolescent with attention-deficit/hyperactivity disorder and mild mental retardation.Journal of child and adolescent psychopharmacology, 19 3
-
R. Barkley, Mary Poillion (1994)
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and TreatmentBehavioral Disorders, 19
-
B. Handen, R. Sahl, A. Hardan (2008)
Guanfacine in Children with Autism and/or Intellectual DisabilitiesJournal of Developmental & Behavioral Pediatrics, 29
-
10.1176/appi.books.9780890425596
-
M. Aman, B. Buican, L. Arnold (2003)
Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies.Journal of child and adolescent psychopharmacology, 13 1
-
J. Elia, V. Vetter (2010)
Cardiovascular Effects of Medications for the Treatment of Attention-Deficit Hyperactivity DisorderPediatric Drugs, 12
-
Alceu Filho, Rafael Bodanese, Tatiana Silva, Júlia Alvares, M. Aman, L. Rohde (2005)
Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation.Journal of the American Academy of Child and Adolescent Psychiatry, 44 8
-
A. Görtz, M. Döpfner, A. Nowak, B. Bonus, G. Lehmkuhl (2002)
Ist das Selbsturteil Jugendlicher bei der Diagnostik von Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen hilfreich?Kindheit Und Entwicklung, 11
-
B. Handen, C. Johnson, M. Lubetsky (2000)
Efficacy of Methylphenidate Among Children with Autism and Symptoms of Attention-Deficit Hyperactivity DisorderJournal of Autism and Developmental Disorders, 30
-
B. Handen, Heidi Feldman, Andrea Lurier, P. Murray (1999)
Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD.Journal of the American Academy of Child and Adolescent Psychiatry, 38 7
-
R. Hunt, R. Minderaa, D. Cohen (1986)
The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: a comparison with placebo and methylphenidate.Psychopharmacology bulletin, 22 1
-
W. Pelham, K. Greenslade, M. Vodde-Hamilton, D. Murphy, J. Greenstein, E. Gnagy, K. Guthrie, Mark Hoover, R. Dahl (1990)
Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.Pediatrics, 86 2
-
A. Fernández-Jaén, D. Fernández‐Mayoralas, B. Pérez, N. Jareño, María Díaz (2010)
Atomoxetine for attention deficit hyperactivity disorder in mental retardation.Pediatric neurology, 43 5
-
W. Pelham, E. Gnagy, Andrea Chronis, Lisa Burrows-MacLean, G. Fabiano, Adia Onyango, David Meichenbaum, A. Williams, Helen Aronoff, Randi Steiner (1999)
A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder.Pediatrics, 104 6
-
E. Taylor, M. Döpfner, J. Sergeant, P. Asherson, T. Banaschewski, J. Buitelaar, D. Coghill, M. Danckaerts, A. Rothenberger, E. Sonuga-Barke, H. Steinhausen, A. Zuddas (2004)
European clinical guidelines for hyperkinetic disorder – first upgradeEuropean Child & Adolescent Psychiatry, 13
-
C. and, E. Billstedt (2000)
Autism and Asperger syndrome: coexistence with other clinical disordersActa Psychiatrica Scandinavica, 102
-
B. Handen, H. Feldman, A. Gosling, A. Breaux, S. McAuliffe (1991)
Adverse side effects of methylphenidate among mentally retarded children with ADHD.Journal of the American Academy of Child and Adolescent Psychiatry, 30 2
-
10.1017/S0012162200000451
-
H. Peyre, N. Hoertel, F. Limosin, C. Dubuc, Paris Cité (2014)
15. CADDRA. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). 3rd ed. Toronto, ON: Canadian ADHD Practice Guidelines; 2011. -
B. Handen, A. Breaux, J. Janosky, S. McAuliffe, H. Feldman, A. Gosling (1992)
Effects and noneffects of methylphenidate in children with mental retardation and ADHD.Journal of the American Academy of Child and Adolescent Psychiatry, 31 3
-
S. Faraone, J. Biederman, T. Spencer, T. Wilens, L. Seidman, E. Mick, A. Doyle (2000)
Attention-deficit/hyperactivity disorder in adults: an overviewBiological Psychiatry, 48
-
K. Lyseng-Williamson, G. Keating (2012)
Extended- Release Methylphenidate (Ritalin® LA)Drugs, 62
-
M. Döpfner, T. Banaschewski, J. Schmidt, H. Uebel, K. Schmeck, W. Gerber, M. Günter, U. Knölker, M. Gehrke, F. Hässler, E. Möhler, M. Brünger, C. Ose, R. Fischer, F. Poustka, G. Lehmkuhl, A. Rothenberger (2003)
Langzeitwirksames Methylphenidat bei Kindern mit Aufmerksamkeitsdefizit-HyperaktivitätsstörungenNervenheilkunde, 22
-
P. Asherson, T. Banaschewski, J. Buitelaar, D. Coghill, M. Danckaerts, M. Doepfner, A. Rothenberger, P. Santosh, J. Sergeant, E. Sonuga-Barke, H. Steinhausen, Eric Taylor, A. Zuddas (2008)
[Joint position of the Guideline Group of the European Network for Hyperkintetic Disorders (EUNETHYDIS) and the German Central ADHD Network for ECG Recording on methylphenidate prescriptions].Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 36 6
-
S. Faraone, J. Buitelaar (2010)
Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysisEuropean Child & Adolescent Psychiatry, 19
-
T. Banaschewski, Veit Roessner, R. Dittmann, P. Santosh, A. Rothenberger (2004)
Non–stimulant medications in the treatment of ADHDEuropean Child & Adolescent Psychiatry, 13
-
B. Bolea-Alamañac, D. Nutt, M. Adamou, P. Asherson, S. Bazire, D. Coghill, D. Heal, U. Müller, J. Nash, P. Santosh, K. Sayal, E. Sonuga-Barke, S. Young (2014)
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology, 28
-
B. Handen, A. Breaux, Amy Gosling, D. Ploof, Heidi Feldman (1990)
Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.Pediatrics, 86 6
-
P. Strømme, T. Diseth (2000)
Prevalence of psychiatric diagnoses in children with mental retardation: data from a population‐based studyDevelopmental Medicine & Child Neurology, 42
-
B. Handen, J. Janosky, S. McAuliffe (1997)
Long-Term Follow-Up of Children with Mental Retardation/Borderline Intellectual Functioning and ADHDJournal of Abnormal Child Psychology, 25
-
M. Aman, Tristram Smith, L. Arnold, P. Corbett-Dick, R. Tumuluru, Jill Hollway, S. Hyman, Marissa Mendoza-Burcham, X. Pan, D. Mruzek, L. Lecavalier, L. Levato, Laura Silverman, B. Handen (2014)
A review of atomoxetine effects in young people with developmental disabilities.Research in developmental disabilities, 35 6
-
Mary Horton-Salway (2011)
Repertoires of ADHD in UK newspaper mediaHealth:, 15
-
M. Ledbetter (2005)
Atomoxetine use associated with onset of a motor tic.Journal of child and adolescent psychopharmacology, 15 2
-
L. Greenhill, J. Swanson, B. Vitiello, M. Davies, Walter Clevenger, Min-Ru Wu, L. Arnold, H. Abikoff, O. Bukstein, C. Conners, G. Elliott, L. Hechtman, S. Hinshaw, B. Hoza, P. Jensen, H. Kraemer, J. March, J. Newcorn, J. Severe, K. Wells, T. Wigal (2001)
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial.Journal of the American Academy of Child and Adolescent Psychiatry, 40 2
-
R. Barkley (2006)
Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment, 3rd ed. -
E. Emerson (2003)
Prevalence of psychiatric disorders in children and adolescents with and without intellectual disability.Journal of intellectual disability research : JIDR, 47 Pt 1
-
B. Handen, S. McAuliffe, Lourdes Caro-Martinez (1996)
Stimulant medication effects on learning in children with mental retardation and ADHDJournal of Developmental and Physical Disabilities, 8
-
L. Arnold (2013)
Commentary: Filling out the evidence base for treatment of attention-deficit hyperactivity disorder symptoms in children with intellectual and developmental disability: conclusions for clinicians--a response to Simonoff et al. (2013).Journal of Child Psychology and Psychiatry, 54
-
D. Pearson, D. Lane, Cynthia Santos, C. Casat, S. Jerger, K. Loveland, L. Faria, Rosleen Mansour, Jill Henderson, Christa Payne, J. Roache, D. Lachar, L. Cleveland (2004)
Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response.Journal of the American Academy of Child and Adolescent Psychiatry, 43 6
-
M. Aman, C. Pejeau, P. Osborne, J. Rojahn, B. Handen (1996)
Four-year follow-up of children with low intelligence and ADHD.Research in developmental disabilities, 17 6
-
Cynthia Johnson, B. Handen, M. Lubetsky, Kelley Sacco (1994)
Efficacy of Methylphenidate and Behavioral Intervention on Classroom Behavior in Children with ADHD and Mental RetardationBehavior Modification, 18
- Publisher
- Emerald Publishing
- Copyright
- Copyright © Emerald Group Publishing Limited
- ISSN
- 2044-1282
- DOI
- 10.1108/AMHID-06-2015-0032
- Publisher site
- See Article on Publisher Site
Abstract
Purpose – Attention disorders in people with intellectual disabilities (ID) is common. Current drug treatments are based on the literature in people without ID. The purpose of this paper is to present a review of the drug treatment of Attention Deficit Hyperactivity Disorder (ADHD) in people with ID in the German and English languages literature with the aim of exploring the current evidence base. Design/methodology/approach – The paper provides a general review of the evidence base on drug treatment of ADHD in people with ID from the German and English language literature. Findings – Studies and practice guidance on ADHD in both languages are similar with more information published in English. Much of the evidence on drug therapy to treat ADHD in people with ID is based on studies in children. The literature on ADHD in children without ID is helpful but not specific to all people with ID who have ADHD. The response rates to medication to treat ADHD in people with ID are lower than in people without ID. The occurrence of side effects from medication is more common in people with ID. Co-morbid disorders are often present in people with ADHD that could affect study findings. Practical implications – Medication used to treat ADHD is effective when treating ADHD in people with ID. Prescribers should be aware of guidelines on medication and their potential drug interactions and side effects. Newer drugs could offer more effective treatments because of fewer adverse effects than current medications. Originality/value – The general review offers an insight in to the literature in German and English on ADHD in ID comparing what is published in both languages.
Journal
Advances in Mental Health and Intellectual Disabilities – Emerald Publishing
Published: Jan 4, 2016